|
1
|
Isolated IgG4-associated autoimmune hepatitis or the first manifestation of IgG4-related disease?
|
2023 Vol.22(4):415-417
|
|
Cosentino C, Clayton-Chubb D, McLean C, Roberts SK, Kemp W |
[Abstract]
(112)
[HTML 0 KB][PDF 0 KB]
(3399)
|
|
|
|
|
2
|
AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway
|
2024 Vol.23(1):43-51
|
|
Zhang QQ, Chen Q, Cao P, Shi CX, Zhang LY, Wang LW, Gong ZJ |
[Abstract]
(98)
[HTML 0 KB][PDF 0 KB]
(447)
|
|
|
|
|
3
|
Comment on “Robotic surgery and liver transplantation: A single-center experience of 501 robotic donor hepatectomies”
|
2024 Vol.23(1):109-110
|
|
Liu XY, Xu YY, Xiang Z, Zheng SS |
[Abstract]
(91)
[HTML 0 KB][PDF 0 KB]
(440)
|
|
|
|
|
4
|
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease
|
2024 Vol.23(3):241-248
|
|
Sun C, Goh GB, Chow WC, Chan WK, Wong GL, Seto WK, Huang YH, Lin HC, Lee IC, Lee HW, Kim SU, Wong VW, Fan JG |
[Abstract]
(122)
[HTML 0 KB][PDF 0 KB]
(300)
|
|
|
|
|
5
|
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives
|
2024 Vol.23(3):221-227
|
|
Gavriilidis P, Pawlik TM, Azoulay D |
[Abstract]
(227)
[HTML 0 KB][PDF 0 KB]
(291)
|
|
|
|
|
6
|
Post-fontan circulation hepatocellular carcinoma: Open and laparoscopic hepatectomy
|
2024 Vol.23(1):90-93
|
|
Ho KKY, She WH, Tsang SHY, Lo KS, Cheung TT |
[Abstract]
(109)
[HTML 0 KB][PDF 0 KB]
(285)
|
|
|
|
|
7
|
A robust genomic-based prognostic model for the assessment of cancer stemness and survival for patients with hepatocellular carcinoma
|
2024 Vol.23(1):97-102
|
|
Du CL, Wei SY, Chen YH, Chen KJ |
[Abstract]
(91)
[HTML 0 KB][PDF 0 KB]
(278)
|
|
|
|
|
8
|
Low skeletal muscle mass and high visceral adiposity are associated with recurrence of acute cholecystitis after conservative management: A propensity score-matched cohort study
|
2024 Vol.23(1):64-70
|
|
Koya Y, Shibata M, Maruno Y, Sakamoto Y, Oe S, Miyagawa K, Honma Y, Harada M |
[Abstract]
(86)
[HTML 0 KB][PDF 0 KB]
(278)
|
|
|
|
|
9
|
Pancreatic panniculitis as the first presentation of pancreatic ductal adenocarcinoma
|
2024 Vol.23(1):106-108
|
|
Zhu WF, Fang S, Qiao JJ |
[Abstract]
(103)
[HTML 0 KB][PDF 0 KB]
(274)
|
|
|
|
|
10
|
Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment
|
2024 Vol.23(3):326-330
|
|
Zhu F, Wang YM, Ni M, Liang Y, Huang JH, Wang XH, Cheng F, Lu L |
[Abstract]
(95)
[HTML 0 KB][PDF 0 KB]
(268)
|
|
|
|
|
11
|
Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension
|
2024 Vol.23(1):4-13
|
|
Sheng JY, Meng ZF, Li Q, Yang YS |
[Abstract]
(112)
[HTML 0 KB][PDF 0 KB]
(259)
|
|
|
|
|
12
|
Mesenteric adipose tissue B lymphocytes promote intestinal injury in severe acute pancreatitis by mediating enteric pyroptosis
|
2024 Vol.23(3):300-309
|
|
Huang Q, Liu JW, Dong HB, Wei ZJ, Liu JZ, Ren YT, Jiang X, Jiang B |
[Abstract]
(89)
[HTML 0 KB][PDF 0 KB]
(257)
|
|
|
|
|
13
|
Acute suppurative terminal cholangitis: Clinical characteristics of a new subtype of acute cholangitis
|
2024 Vol.23(3):293-299
|
|
Zhu RT, Li Y, Zhang CX, Wang WJ, Liang RP, Li J, Bai K, Sun YL |
[Abstract]
(86)
[HTML 0 KB][PDF 0 KB]
(256)
|
|
|
|
|
14
|
Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma
|
2024 Vol.23(3):257-264
|
|
Ng KT, Pang L, Wang JQ, She WH, Tsang SHY, Lo CM, Man K, Cheung TT |
[Abstract]
(130)
[HTML 0 KB][PDF 0 KB]
(249)
|
|
|
|
|
15
|
Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study
|
2024 Vol.23(3):249-256
|
|
Wang MD, Yuan C, Wang KC, Wang NY, Liang YJ, Zhu H, Tong XM, Yang T |
[Abstract]
(107)
[HTML 0 KB][PDF 0 KB]
(248)
|
|
|
|
|
16
|
Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach
|
2024 Vol.23(3):317-321
|
|
Parente P, Angerilli V, Zamboni G, Sparaneo A, Fiordelisi F, Di Candia L, Fassan M, Graziano P |
[Abstract]
(95)
[HTML 0 KB][PDF 0 KB]
(242)
|
|
|
|
|
17
|
Thanks
|
2023 Vol.22(6):661-A9
|
|
|
[Abstract]
(100)
[HTML 0 KB][PDF 43 KB]
(234)
|
|
|
|
|
18
|
Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidence
|
2024 Vol.23(2):146-153
|
|
Muller PC, Pfister M, Eshmuminov D, Lehmann K |
[Abstract]
(97)
[HTML 0 KB][PDF 0 KB]
(232)
|
|
|
|
|
19
|
Interventional treatment options for management of delayed arterial hemorrhage after major hepato-pancreatic-biliary surgery
|
2023 Vol.22(6):648-649
|
|
Ielpo B, Alborino S, Melloul E, Salvatori F, Lai Q, Rossi M, Demartines N, Di Saverio S |
[Abstract]
(88)
[HTML 0 KB][PDF 0 KB]
(231)
|
|
|
|
|
20
|
Animal models of hepatitis E infection: Advances and challenges
|
2024 Vol.23(2):171-180
|
|
Xiang Z, He XL, Zhu CW, Yang JJ, Huang L, Jiang C, Wu J; Chinese Consortium for the Study of Hepatitis E (CCSHE) |
[Abstract]
(91)
[HTML 0 KB][PDF 0 KB]
(227)
|
|
|
|
